The accompanying notes are an integral
part of these consolidated financial statements.
The accompanying notes are an integral
part of these consolidated financial statements.
The accompanying notes are an integral
part of these consolidated financial statements.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – NATURE OF OPERATIONS
Our consolidated financial statements
include the accounts of Zurvita Holdings, Inc. (referred to herein as the “Company,” “Zurvita Holdings,”
“we,” “us” or “our”) and our wholly-owned subsidiary Zurvita, Inc. (Zurvita). Material intercompany
transactions and balances have been eliminated upon consolidation. Zurvita Holdings is a national network marketing company offering
high-quality products targeting individuals and families with a strong foothold in small town America and expanding into national
urban centers. Products are sold through Zurvita’s network of independent sales consultants.
Management’s Assessment of
Liquidity
Since the Company’s inception, the
Company has primarily met its operating cash requirements through equity contributions from The Amacore Group, Inc. (Amacore),
who was the Company’s sole shareholder prior to July 30, 2009. Subsequent to July 30, 2009, the Company has sold several
series of preferred stock for gross proceeds of $6.8 million to another related party. We are using the proceeds from the
sale of preferred stock to subsidize the Company’s operations as the Company’s revenues and operating cash flows are
not currently sufficient to support the Company’s current operations.
At January 31, 2013, the Company had negative
working capital of approximately $1.5 million, an accumulated deficit of approximately $21 million and positive cash flows from
operating activities of approximately $156 thousand for the six months then ended. Since the date of inception, the Company has
used approximately $9.9 million in operations.
Additional cash resources may be required
should the Company not meet its sales targets, exceed its projected operating costs, wish to accelerate sales or complete one
or more acquisitions or if unanticipated expenses arise or are incurred.
The Company does not currently maintain
a line of credit or term loan with any commercial bank or other financial institution and has not made any other arrangements
to obtain additional financing. We can provide no assurance that we will not require additional financing. Likewise,
we can provide no assurance that if we need additional financing that it will be available in an amount or on terms acceptable
to us, if at all. If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained
on terms favorable to us, we may be unable to execute our business plan or pay our costs and expenses as they are incurred, which
could have a material, adverse effect on our business, financial condition and results of operations.
NOTE 2 – SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
Revenue Recognition
Administrative Websites
Company’s independent representatives
pay a fee to the Company entitling them to use of websites that facilitate their business operations. Revenue is recognized
ratably over the website subscription period.
Advertising Sales
The Company markets subscriptions to a
service that facilitates the ability of customers, typically small business owners, to display commercial advertising via an on-line
search directory. Revenue is recognized ratably over the advertising subscription period.
Commissions
The Company is paid a commission for its
sales of third-party products. Commissions are recognized as products are sold and services performed and the Company has accomplished
all activities necessary to complete the earnings process.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
Consumable Products
The Company markets a line of nutritional
drinks under the “Zeal” umbrella. Revenue from the sale of these consumable products is recognized upon shipment of
the product.
Marketing Fees and Materials
The Company also earns ancillary revenue
from the sale of marketing materials to sales consultants. Revenue is recognized when marketing materials are delivered.
Membership Fees
The Company recognizes revenues from membership
fees as earned for the sales of other lifestyle discount benefit programs, such as household protection and personal financial
services. These arrangements are generally renewable monthly and revenue is recognized over the renewal period.
Refunds and Chargebacks
The Company records a reduction in
revenue for estimated refunds and chargebacks from credit card companies based upon actual history and management’s evaluation
of current facts and circumstances. Refunds and chargebacks totaled approximately $77 thousand and $23 thousand for
the three months ended January 31, 2013 and 2012, respectively, and $116 thousand and $33 thousand for the six months ended January
31, 2013 and 2012, respectively, and were recorded as a reduction of revenue in the accompanying statements of operations. Estimates
for an allowance for refunds and chargebacks totaling approximately $30 thousand and $10 thousand is included in accrued expenses
in the accompanying consolidated balance sheets as of January 31, 2013 and July 31, 2012, respectively.
Selling and Marketing Costs
The Company classifies merchant account
fees, fulfillment costs and lead cost not identifiable with specific product sales within selling and marketing costs within the
Statement of Operations.
Concentration of Credit Risk
All of the Company’s credit card
processing is with one merchant processor, as well as all marketing sales commission payments are calculated by a third-party
service provider.
Use of Estimates
The preparation of these consolidated
financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including
the allowance for sales refunds and chargebacks, capitalization of certain assets, depreciable/amortizable lives, impairment of long-lived
assets, determination of amount of allowance for doubtful accounts, the fair value of marketable securities, the expected volatility
of common stock, and the fair value of common stock and warrants as well as the allocation of proceeds from the issuance of debt
and equity instruments. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under
different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are
reasonable.
Accounts Receivable
Accounts receivable are stated at estimated
net realizable value. Accounts receivable are primarily comprised of balances due from memberships, net of estimated allowances
for uncollectible accounts. In determining collectability, historical trends are evaluated and specific customer issues are reviewed
to arrive at appropriate allowances. At January 31, 2013 and July 31, 2012, no allowance was deemed necessary therefore none was
recorded.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
Property, Plant and Equipment
Property, plant and equipment are recorded
at cost. The cost of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred.
The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the property
as follows: computer hardware, 3 years; furniture and fixtures, 7 years; equipment and machinery, 5 years; and leasehold improvements,
the shorter of the term of the lease or the life of the asset. When assets are retired or otherwise disposed of, the assets and
related accumulated depreciation are eliminated from the accounts and the resulting gain or loss is reflected in the results of
operations.
Share-Based Compensation
The fair value of each stock option award is estimated on the
date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions
as to dividend yield, volatility, an appropriate risk-free interest rate and the expected life of the option. Many of these assumptions
require management’s judgment. The Company’s stock volatility assumption is based upon its historical stock price
fluctuations. The Company uses historical data to estimate option forfeiture rates and the expected term of options granted. The
risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve at the time of
grant.
Convertible Instruments
The Company reviews the terms of convertible
debt and preferred stock for indications requiring bifurcation, and separate accounting for the embedded conversion feature. Generally,
embedded conversion features where the ability to physical or net-share settle the conversion option is not within the control
of the Company or the number of shares is variable are bifurcated and accounted for as derivative financial instruments. (See
Derivative Financial Instruments
below.) Bifurcation of the embedded derivative instrument requires allocation of the proceeds
first to the fair value of the embedded derivative instrument with the residual allocated to the host instrument. The resulting
discount to the debt instrument or to the redemption value of convertible preferred securities is accreted through periodic charges
to interest expense over the term of the note or to dividends over the period to earliest conversion date using the effective
interest rate method, respectively.
Derivative Financial Instruments
The Company does not use derivative financial
instruments to hedge exposures to cash-flow or market risks. However, certain other financial instruments, such as warrants to
purchase the Company’s common stock and the embedded conversion features of debt and preferred instruments that are not
considered indexed to the Company’s common stock are classified as liabilities when either (a) the holder possesses rights
to net-cash settlement, (b) physical or net share settlement is not within the control of the Company, or (c) based on its anti-dilutive
provisions. In such instances, net-cash settlement is assumed for financial accounting and reporting. Such financial instruments
are initially recorded at fair value and subsequently adjusted to fair value at the close of each reporting period. Fair value
for option-based derivative financial instruments is determined using the Black-Scholes Option Pricing Model.
Income Taxes
The Company accounts for income taxes
using an asset and liability method pursuant to which deferred tax assets and liabilities are recognized for future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to reverse. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided against
deferred tax assets based on the weight of available evidence when it is more likely than not that some or all of the deferred
tax assets will not be realized.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
When tax returns are filed, it is highly
certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty
about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax
position is recognized in the financial statements in the period during which, based on all available evidence, we believe it
is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation
processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not
recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized
upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds
the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet
along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and
penalties associated with unrecognized tax benefits are classified as income tax expense in the statement of operations.
Fair Value Measurements
U.S. GAAP defines fair value as the price
that would be received to sell an asset or paid to transfer a liability to a third party with the same credit standing (an exit
price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants
on the measurement date. In many cases, the exit price and the transaction (or entry) price will be the same at initial recognition.
However, in certain cases, the transaction price may not represent fair value. Fair value is a market-based measurement determined
based on a hypothetical transaction at the measurement date, considered from the perspective of a market participant, not based
solely upon the perspective of the reporting entity. When quoted prices are not used to determine fair value, consideration is
given to three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. Entities
are required to determine the most appropriate valuation technique to use, given what is being measured and the availability of
sufficient inputs. Inputs to fair valuation techniques are prioritized, allowing for the use of unobservable inputs to the extent
that observable inputs are not available. The applicable guidance establishes a three-level hierarchy, based on the priority of
the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active
markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset or liability’s
classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels
are defined as follows:
Level 1
|
Unadjusted
quoted prices in active markets for identical assets or liabilities.
|
|
|
Level 2
|
Quoted prices in markets
that are not active or inputs that are observable either directly or indirectly. Level 2 inputs include quoted prices for
similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other
inputs that are observable or can be derived principally from or corroborated by observable market data for substantially
the full term of the assets or liabilities.
|
|
|
Level 3
|
Unobservable inputs that
are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Unobservable
inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing
the asset or liability. Level 3 assets and liabilities include those whose values are determined using pricing
models, discounted cash flow methodologies, or similar techniques, as well as those for which the determination of fair value
requires significant management judgment or estimation.
|
(Loss) Per Share
Basic (loss) per share is calculated by
dividing net (loss) available to common stockholders by the weighted average number of shares of common stock outstanding for
the period. Diluted (loss) per share is calculated by dividing the net (loss) by the weighted average number of shares of common
stock outstanding for the period, adjusted for the dilutive effect, if any, of common stock equivalents, using the treasury stock
method. Convertible debt and warrants, officer, employee and non-employee stock options that are considered potentially dilutive
are included in the fully diluted shares calculation as long as the effect is not anti-dilutive. Contingently issuable shares
are included in the computation of basic loss per share when the issuance of the shares is no longer contingent.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
NOTE 3 – NON CASH INVESTING AND
FINANCING ACTIVITIES
The following table presents a summary
of the various noncash investing and financing transactions that the Company entered into during the six months ended January
31,
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
Financed insurance agreement
|
|
|
90,755
|
|
|
|
48,439
|
|
|
|
|
|
|
|
|
|
|
Interest converted to principal
|
|
|
–
|
|
|
|
68,683
|
|
NOTE 4 – NOTES PAYABLE
Notes payable consist of the following:
|
|
01/31/2013 (Unaudited)
|
|
7/31/2012 (Audited)
|
|
|
|
|
|
Financing agreement; bearing interest at 4.84% per annum; payable in monthly installments
of approximately $2.7 thousand due through July 2013
|
|
|
16,627
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Financing agreement; bearing interest at 4.94% per annum; payable in monthly installments of
approximately $1.9 thousand due through August 2013
|
|
|
13,113
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Financing agreement; bearing interest at 4.47% per annum; payable in monthly installments of
approximately $7.6 thousand due through September 2013
|
|
|
61,014
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on
December 31, 2013
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on
December 31, 2013
|
|
|
600,000
|
|
|
|
600,000
|
|
|
|
|
|
|
|
|
|
|
Promissory note payable; bearing interest of 7.5% per annum; unsecured;
principal payments due monthly approximately $27 thousand through July 2011; currently in default
|
|
|
158,127
|
|
|
|
158,127
|
|
|
|
|
|
|
|
|
|
|
Total notes payable
|
|
|
948,881
|
|
|
|
858,127
|
|
|
|
|
|
|
|
|
|
|
Less current portion
|
|
|
948,881
|
|
|
|
158,127
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
$
|
–
|
|
|
$
|
700,000
|
|
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
On May 3, 2012, the Company issued to
Mark Jarvis a promissory note for $100 thousand. The note accrues interest at 10% per annum and is due on December 31, 2013. As
of January 31, 2013, the Company has not repaid the note plus accrued interest of $6.3 thousand.
On June 13, 2012, the Company issued to
Vicis Capital Managment an on-demand promissory note for $600 thousand. The note accrues interest at 10% per annum and is due
December 31, 2013. As of January 31, 2013, the Company has not repaid the note plus accrued interest of $44.9 thousand.
The Company is in default with respect
to the promissory note due July 2011. Consequently, the Company has accrued interest in accordance with the promissory notes’
default provision at an interest rate of 18%.
NOTE 5 - ACCRUED EXPENSES
Accrued expenses consist of the following
at January 31, 2013 and July 31, 2012:
|
|
01/31/2013 (Unaudited)
|
|
7/31/2012
(Audited)
|
Commissions
|
|
$
|
944,111
|
|
|
$
|
461,295
|
|
Interest
|
|
|
112,915
|
|
|
|
63,280
|
|
Payroll
|
|
|
110,511
|
|
|
|
74,202
|
|
Product
|
|
|
–
|
|
|
|
59,688
|
|
Refund reserve
|
|
|
30,000
|
|
|
|
10,000
|
|
Sales tax payable
|
|
|
163,113
|
|
|
|
93,544
|
|
Services
|
|
|
–
|
|
|
|
30,000
|
|
Unclaimed property
|
|
|
40,513
|
|
|
|
40,513
|
|
Finance agreement
|
|
|
97,506
|
|
|
|
4,722
|
|
Total
|
|
$
|
1,498,669
|
|
|
$
|
837,244
|
|
NOTE 6 - DEFERRED REVENUE
Deferred revenue consists of the following
at January 31, 2013 and July 31, 2012:
|
|
01/31/2013 (Unaudited)
|
|
7/31/2012
(Audited)
|
Advertising
|
|
$
|
592
|
|
|
$
|
3,261
|
|
Conferences
|
|
|
120,897
|
|
|
|
–
|
|
Direct response media
|
|
|
24,939
|
|
|
|
24,939
|
|
Member fees
|
|
|
2,591
|
|
|
|
4,932
|
|
Website Fees
|
|
|
106,570
|
|
|
|
47,029
|
|
Total
|
|
$
|
255,589
|
|
|
$
|
80,161
|
|
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
NOTE 7 – ASSETS AND LIABILITIES
MEASURED AT FAIR VALUE
Financial instruments which are measured
at estimated fair value on a recurring basis in the consolidated financial statements include non-compensatory warrants. The fair
value of the warrants was determined by an independent expert valuation specialist using the Black-Scholes Option Pricing Model.
Assets and liabilities measured at estimated
fair value and their corresponding fair value hierarchy is summarized as follows:
January 31,
2013
Fair Value Measurements
at Reporting Date Using
(Unaudited)
|
|
Quoted Prices in Active Markets
for Identical Assets
(Level 1)
|
|
Significant Unobservable Inputs
(Level 3)
|
|
Total Fair Value
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
–
|
|
|
|
298,360
|
|
|
|
298,360
|
|
Total liabilities
|
|
$
|
–
|
|
|
$
|
298,360
|
|
|
$
|
298,360
|
|
July 31, 2012
Fair Value Measurements
at Reporting Date Using
(Audited)
|
|
Quoted Prices in Active Markets
for Identical Assets
(Level 1)
|
|
Significant Unobservable Inputs
(Level 3)
|
|
Total Fair Value
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
–
|
|
|
|
262,800
|
|
|
|
262,800
|
|
Total liabilities
|
|
$
|
–
|
|
|
$
|
262,800
|
|
|
$
|
262,800
|
|
The Company has categorized its assets
and liabilities measured at fair value into the three-level fair value hierarchy, as defined in Note 2, based upon the priority
of inputs to respective valuation techniques. Liabilities included within level 3 of the fair value hierarchy presented in the
preceding table include a share conversion feature and noncompensatory warrants. The valuation methodology for liabilities within
level 3 uses a combination of observable and unobservable inputs in calculating fair value.
The Company
recorded an
unrealized loss of approximately $2 thousand and $35 thousand for the three and six months ended January 31,
2012, respectively. The (loss) has been included in the Statement of Operations caption “(Loss) on change in fair value
of marketable securities.”
The changes in level 3 liabilities measured
at fair value on a recurring basis during the three and six months ended January 31, 2013 and the year ended July 31,2012 are
summarized as follows:
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
|
|
Balance Beginning of Period
|
|
Issuance
|
|
(Gain) Loss Recognized in Earnings
from Change in Fair Value
|
|
Balance End of Period
|
For the Six Months Ended January 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share conversion feature
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
$
|
262,800
|
|
|
$
|
–
|
|
|
$
|
35,560
|
|
|
$
|
298,360
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Beginning of Period
|
|
Issuance
|
|
(Gain) Loss Recognized in Earnings from Change
in Fair Value
|
|
Balance End of Period
|
For the Year Ended July 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share conversion feature
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
$
|
299,600
|
|
|
$
|
–
|
|
|
$
|
(36,800
|
)
|
|
$
|
262,800
|
|
For the six months ended January 31, 2013
, an unrealized loss of $36 thousand is included in earnings within the Statement of Operations caption “Gain on change
in fair value of warrants.”
Fair Value of Financial Instruments
The fair values of accounts receivable,
accounts payable and accrued expenses approximate their carrying values due to the short term nature of these instruments. The
fair values of notes payable approximate their carrying amounts as interest rates on these obligations are representative of estimated
market rates available to the Company on similar instruments.
.
NOTE 8—REDEEMABLE PREFERRED STOCK
The Company is authorized to issue 11.35
million shares of preferred stock with a par value of $0.0001 per share. The following table summarizes the Preferred Stock issuances
and number of Preferred Shares outstanding:
|
|
|
|
Shares Outstanding at
|
Preferred Stock
Issuance
|
|
Date of
Issuance
|
|
January 31,
2013
|
|
July 31,
2012
|
Series A
|
|
|
July 30, 2009
|
|
|
|
1,750,000
|
|
|
|
1,750,000
|
|
Series B
|
|
|
October 6, 2009
|
|
|
|
2,000,000
|
|
|
|
2,000,000
|
|
Series C
|
|
|
January 29, 2010
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
Series C
|
|
|
June 3, 2010
|
|
|
|
2,300,000
|
|
|
|
2,300,000
|
|
Series C
|
|
|
June 9, 2011
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
Series C
|
|
|
December
28, 2011
|
|
|
|
2,800,000
|
|
|
|
2,800,000
|
|
|
|
|
|
|
|
|
11,350,000
|
|
|
|
11,350,000
|
|
Series A, Series B and Series C Redeemable
Preferred Stock is collectively referred to herein as “Redeemable Preferred Stock.”
Significant rights of the Redeemable Preferred
Stock are discussed below:
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
Dividends
The Redeemable Preferred Stock does not
accrue dividends.
Voting Rights
Each holder of the shares of Convertible
Preferred Stock shall have the right to the number of votes equal to the number of Conversion Shares then issuable upon conversion
of the Redeemable Preferred Stock held by such holder in all matters as to which shareholders are required or permitted to vote,
and with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the
holders of Common Stock, and shall be entitled to vote, together with the holders of Common Stock as a single class, with respect
to any question upon which holders of Common Stock have the right to vote; provided, however, as to any holder of Redeemable Preferred
Stock, the right to vote such shares shall be limited to the number of shares issuable to such holder pursuant to certain beneficial
ownership limitations (as listed below) as of the record date for such vote. To the extent permitted under applicable corporate
law, but subject to certain limitations on corporate actions as disclosed below, the Corporation’s shareholders may take
action by the affirmative vote of a majority of all shareholders of the Company entitled to vote on an action. Without limiting
the generality of the foregoing, the Company may take any of the actions by the affirmative vote of the holders of a majority
of the Redeemable Preferred Stock and the Common Stock and other voting common stock equivalents, voting together as one class.
As long as any shares of Redeemable Preferred
Stock are outstanding, the Company shall not, without the written consent or affirmative vote of the holders of no-less than 51
percent of the then outstanding stated value of the Redeemable Preferred Stock consenting or voting as a separate class from the
common stock, the Company shall not, either directly or by amendment, merger, consolidation or otherwise:
(i) amend its certificate
or articles of incorporation in any manner that adversely affects the rights of the holders of Convertible Preferred Stock;
(ii) alter or change adversely
the voting or other powers, preferences, rights, privileges, or restrictions of the Convertible Preferred Stock;
(iii) increase the authorized
number of shares of preferred stock or Convertible Preferred Stock or reinstate or issue any other series of preferred
stock;
(iv) redeem, purchase
or otherwise acquire directly or indirectly any junior securities or any shares pari passu with the Convertible Preferred Stock;
(v) directly or indirectly
pay or declare any dividend or make any distribution in respect of, any junior securities, or set aside any monies for the purchase
or redemption (through a sinking fund or otherwise) of any junior securities or any shares pari passu with the Convertible Preferred
Stock;
(vi) authorize or create
any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to or otherwise pari
passu with the Convertible Preferred Stock; or
(vii) enter into any
agreement with respect to any of the foregoing.
Liquidation Preferences
Upon any liquidation, dissolution or winding-down
of the Company, whether voluntary or involuntary (a “Liquidation”), the holders of the shares of Convertible Preferred
Stock shall be paid in cash, before any payment shall be paid to the holders of common stock, or any other junior stock, an amount
for each share of Convertible Preferred Stock held by such holder equal to the sum of the Stated Value thereof (such applicable
amount payable with respect to a share of Convertible Preferred Stock sometimes being referred to as the “Individual Preferred
Liquidation Preference Payment” and with respect to all shares of Convertible Preferred Stock in the aggregate sometimes
being referred to as the “Aggregate Liquidation Preference Payment”). If, upon such liquidation, dissolution
or winding-up of the Company, whether voluntary or involuntary, the assets to be distributed among the holders of shares of Convertible
Preferred Stock shall be insufficient to permit payment to the holders of Convertible Preferred Stock of an aggregate amount equal
to the Aggregate Liquidation Preference Payment, then the entire assets of the Corporation to be so distributed shall be distributed
ratably among the holders of Convertible Preferred Stock (based on the Individual Preferred Liquidation Preference Payments due
to the respective holders of Convertible Preferred Stock).
The liquidation value of Series A, Series
B and Series C Convertible Preferred Stock was $1.75 million, $2 million and $7.6 million, respectively, as of January 31, 2013.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
Conversion Rights
Each share of Redeemable Preferred Stock
shall be convertible, at the option of the holder thereof, at any time after the original issue date (subject to beneficial ownership
limitations as listed below), and without the payment of additional consideration by the holder thereof, into such number of fully-paid
and nonassessable shares of common stock as is determined by dividing the Stated Value per share, by the Conversion Price in effect
at the time of conversion. The Conversion Price originally
for Series A, B and C shall be $0.0625, $0.25 and $0.25, respectively;
provided, however, that the Conversion Price, and the rate at which shares of Redeemable Preferred Stock may be converted into
shares of common stock, shall be subject to adjustment as a result of stock dividends, stock splits, and subsequent equity sales
at a price lower than the Redeemable Preferred Stock’s Conversion Price. Shares of Convertible Preferred Stock converted
into common stock shall be canceled and shall not be reissued.
At January 31, 2013, Series A, Series
B and Series C Redeemable Preferred Stock is convertible into 28 million, 8 million, 19.2 million, and 11.2 million common shares,
respectively. If the Convertible Preferred Stock had been converted as of January 31, 2013, the aggregate market price of the
common shares for Series A, Series B and Series C would have been approximately $1.3 million, $360 thousand, $864 thousand, and
$504 thousand, respectively.
Beneficial Ownership Limitations
The Company shall not affect any conversion
of the Redeemable Preferred Stock, and a holder shall not have the right to convert any portion of the Redeemable Preferred Stock,
to the extent that, after giving effect to the conversion, such holder (together with such holder’s affiliates, and any
other person or entity acting as a group together with such holder or any of such holder’s affiliates) would beneficially
own in excess 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of
shares of common stock issuable upon conversion of Redeemable Preferred Stock held by the applicable holder. The Beneficial
Ownership Limitation provisions may be waived by such holder, at the election of such holder, upon not less than sixty one (61)
days’ prior notice to the Company, to change the Beneficial Ownership Limitation to 9.99% of the number of shares of the
common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of Convertible
Preferred Stock held by the applicable holder and the provisions of this section shall continue to apply. Upon such
a change by a holder of the Beneficial Ownership Limitation from such 4.99% limitation to such 9.99% limitation, the Beneficial
Ownership Limitation shall not be further waived by such holder.
Redemption Rights of the Company
Shares of the Redeemable Preferred Stock
shall be redeemable, in whole or in part, at the option of the Company, by resolution of its Board of Directors at any time after
the original issue date and before the first (1st) anniversary of the original issue date at a price equal to one hundred and
ten percent (110%) of the Stated Value.
Redemption Rights of Holder
The Redeemable Preferred Stock is redeemable
for cash in an amount representing the Stated Value of outstanding Convertible Preferred Stock. The following events give rise
to a redemption triggering event:
|
·
|
The
Company shall be
party to a change
of control transaction;
|
|
·
|
The
Company shall fail
to have available
a sufficient number
of authorized and
unreserved shares
of common stock
to issue to such
holder upon a conversion;
|
|
·
|
Unless
specifically addressed
elsewhere in the
Convertible Preferred
Stock’s Certificate
of Designation
as a Triggering
Event, the Corporation
shall fail to observe
or perform any
other covenant,
agreement or warranty
contained in the
Certificate of
Designation, and
such failure or
breach shall not,
if subject to the
possibility of
a cure by the Company,
have been cured
within 20 calendar
days after the
date on which written
notice of such
failure or breach
shall have been
delivered;
|
|
·
|
There
shall have occurred
a bankruptcy event
or material monetary
judgment;
|
If the Company fails to pay the redemption
amount as a result of a triggering event on the date it is due, interest will accrue at a rate equal to the lesser of 18% per
year, or the maximum rate permitted by applicable law, accruing daily from the date of the triggering event until the amount is
paid in full.
Events that may result in the redemption
for cash of preferred stock, and that are not within a company’s control may require the preferred stock to be classified
outside of stockholders’ equity (in the mezzanine section). All of the above triggering events are presumed not to be within
our control. Accordingly, these instruments are recorded in our balance sheet in the caption Redeemable Preferred Stock, which
is outside of stockholders’ equity. Management estimates the probability of the triggering events to be remote due to the
Company’s affiliation with stockholders that represent a majority of the outstanding common and preferred stock. Therefore,
the carrying value of the preferred stock has not been increased to the full redemption value.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
The reason the carrying value is not equal
to the redemption amount is due to the allocation of value to certain warrants issued in connection with the preferred stock.
The following table summarizes for each preferred stock issuance the value allocated to the warrants and preferred stock:
Preferred Stock
Issuance
|
|
Date of
Issuance
|
|
Total
Proceeds Received
|
|
Value
Allocated to Warrants
|
|
Preferred
Stock Carrying Amount
|
Series A
|
|
|
July 30, 2009
|
|
|
$
|
1,750,000
|
|
|
$
|
539,000
|
|
|
$
|
1,211,000
|
|
Series B
|
|
|
October 6, 2009
|
|
|
|
2,000,000
|
|
|
|
930,838
|
|
|
|
1,069,162
|
|
Series C
|
|
|
January 29, 2010
|
|
|
|
1,000,000
|
|
|
|
431,415
|
|
|
|
568,585
|
|
Series C
|
|
|
June 3, 2010
|
|
|
|
2,300,000
|
|
|
|
598,000
|
|
|
|
1,702,000
|
|
Series C
|
|
|
June 9, 2011
|
|
|
|
1,500,000
|
|
|
|
24,000
|
|
|
|
1,476,000
|
|
Series C
|
|
|
December
28, 2011
|
|
|
|
2,800,000
|
|
|
|
1,456
|
|
|
|
2,798,544
|
|
Total
|
|
|
|
|
|
$
|
11,350,000
|
|
|
$
|
2,524,709
|
|
|
$
|
8,825,291
|
|
NOTE 9 - COMMON STOCK
The Company has authorized 300 million
common shares with a par value of $0.0001 per share. On all matters required by law to be submitted to a vote of the holders of
common stock, each share of common stock is entitled to one vote per share.
For the three and six months ended January
31, 2013, approximately $0 thousand and $1.2 million, respectively, of stock-based compensation expense was recognized, as a result
of shares issued to the members of the board for compensation of services. For the three and six months ended January 31, 2012,
approximately $18 thousand and $47 thousand, respectively, of stock-based compensation expense was recognized, as a result of
various share issuances..
On May 8, 2012, the Company and Amacore
entered into a Stock Purchase Agreement (the “Amacore Purchase Agreement”) whereby the Company purchased 37.21 million
shares of the Company’s common stock from Amacore. Pursuant to the Amacore Purchase Agreement, the Company paid to Amacore
a purchase price equal to $300 thousand. The treasury stock was recorded at cost.
On May 8, 2012, the Company and Infusion
entered into a Stock Purchase Agreement (the “Infusion Purchase Agreement”) whereby the Company purchased 15.2 million
shares of the Company’s common stock from Infusion. Pursuant to the Infusion Purchase Agreement, the Company paid to Infusion
a purchase price equal to $100 thousand. The treasury stock was recorded at cost.
On December 26, 2012, the Company issued
$6.5 million shares from treasury to each of the four board members for compensation of services. The expense was recorded at
the fair value of the Company’s common stock as of the issuance date.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
NOTE 10–COMPENSATORY WARRANTS
During 2009, Zurvita’s Board of
Directors adopted the 2009 Incentive Stock Plan (the 2009 Plan), pursuant to which we reserved for issuance 6 million shares of
Zurvita common stock to be used as awards to employees, directors, consultants, and other service providers. The purpose of the
2009 Plan is to provide an incentive to attract and retain officers, consultants, advisors and employees whose services are considered
valuable, to encourage a sense of proprietorship and to stimulate an active interest of such persons into Zurvita’s development
and financial success. Under the 2009 Plan, Zurvita is authorized to issue incentive stock options intended to qualify under Section
422 of the Code, non-qualified stock options, stock appreciation rights, performance shares, restricted stock and long term incentive
awards. The 2009 Plan is administered by the Board’s designated Compensation Committee.
The following table summarizes the status
of all warrants outstanding and exercisable at January 31, 2013.
Outstanding and Exercisable Warrants
|
Range of Exercise Prices
|
|
Number of Warrants
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Life in
Years
|
$0.06 to $0.49
|
|
|
71,908,000
|
|
|
$
|
0.17
|
|
|
|
4.11
|
|
$0.50 to $0.99
|
|
|
100,000
|
|
|
$
|
0.75
|
|
|
|
2.03
|
|
|
|
|
72,008,000
|
|
|
$
|
0.17
|
|
|
|
4.11
|
|
Assumptions used to determine the fair
value of the compensatory warrants granted during the three months ended January 31, 2013 and during the year ended July 31, 2012
are as follows.
|
|
January 31, 2013
|
|
July 31, 2012
|
Expected dividends
|
|
0%
|
|
0%
|
Expected volatility
|
|
66%
|
|
70%
|
Risk free interest rate
|
|
0.27% - 0.53%
|
|
0.25% - 0.94%
|
Expected life
|
|
5 years
|
|
5 years
|
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
The following table summarizes the activity
for compensatory warrants classified as equity for the three months ended January 31, 2013.
|
|
Compensatory Equity Warrants
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term
|
|
Aggregate Intrinsic Value
|
Outstanding at July 31, 2012
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
3.00
|
|
|
$
|
–
|
|
Granted
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Exercised
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Cancelled or Expired
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Outstanding at January 31, 2013
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
3.00
|
|
|
$
|
–
|
|
Exercisable at January 31, 2013
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
3.00
|
|
|
$
|
–
|
|
A summary of the status of the Company's
non-vested compensatory equity warrants as of January 31, 2013, and the changes during the six months ended January 31, 2013,
is presented below.
|
|
Compensatory Warrants
|
|
Weighted Average Grant-Date Fair Value
|
|
Non-vested at July 31, 2012
|
|
|
|
37,500
|
|
|
$
|
0.003
|
|
|
Issued
|
|
|
|
–
|
|
|
|
–
|
|
|
Vested
|
|
|
|
(37,500
|
)
|
|
|
–
|
|
|
Exercised
|
|
|
|
–
|
|
|
|
–
|
|
|
Non-vested
at January 31, 2013
|
|
|
|
–
|
|
|
$
|
–
|
|
Non-compensatory Liability Warrants
There were approximately 66.4 million
non-compensatory warrants outstanding as of January 31, 2013, all of which were classified as liabilities. These warrants are
classified as liability instruments as net share settlement is not considered within the Company’s control or certain exercise
prices are not fixed which has the potential to cause a variable number of shares and/or value exchange upon exercise.
The fair value of each option award classified
as a liability on the balance sheets is estimated on the date of the grant using the Black-Scholes Pricing Model and the assumptions
noted in the following table. The stock price used approximates the market price less a marketability discount of 30%. Expected
volatility was determined by independent valuation specialist. The risk-free rate for periods within the contractual life of the
option is based on the U.S. Treasury Strip yield curve in effect at the time of grant. The expected term of options granted represents
the period of time that options granted are expected to be outstanding.
Assumptions used to determine the fair
value of the non-compensatory warrants outstanding during the three months ended January 31, 2013 and granted at and during the
year ended July 31, 2012 are as follows.
|
|
January 31, 2013
|
|
July 31, 2012
|
Expected dividends
|
|
0%
|
|
0%
|
Expected volatility
|
|
66%
|
|
70%
|
Risk free interest rate
|
|
0.53% - 1.17%
|
|
0.69% - 1.28%
|
Expected life
|
|
7 years
|
|
7 years
|
There were no vested or non-vested compensatory
liability issuances, exercises or expirations during the six months ended January 31, 2013.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS- CONTINUED
(UNAUDITED)
Stock-Based
Compensation Expense
For
the six months ended January 31, 2013 and 2012, the Company recognized stock-based compensation expense, including both expense
related to compensatory warrants and expense related to share awards, with the Statement of Operations as follows:
|
|
For the Six Months Ended
January 31, 2013
|
|
For the Six Months Ended
January 31, 2012
|
Payroll and employee benefits
|
|
$
|
1,179,225
|
|
|
$
|
47,362
|
|
Total
|
|
$
|
1,179,225
|
|
|
$
|
47,362
|
|
On December 26, 2012, the Company issued
6.5 million shares from treasury to each of the four board members for compensation of services. The expense was recorded at the
fair value of the Company’s common stock as of the issuance date.
NOTE 11 - RELATED PARTY TRANSACTIONS
Commissions Paid
There are immediate family members of
Mr. Jarvis, who operate as independent sales consultants who were paid commission compensation which approximated $48 and $104
thousand, respectively, for the three and six months ended January 31, 2013, and approximately $36 and $63 thousand, respectively,
for the three and six months ended January 31, 2012. These payments were for work they performed on behalf of the Company.
Note Payable to Mark Jarvis
On June 13, 2012, the Company issued to
Mark Jarvis an on-demand promissory note for $100 thousand. The note accrued interest at 10% per annum. As of January 31, 2013,
the Company had not repaid the note plus accrued interest of $6.1 thousand.
Note Payable to Vicis Capital Management
On May 3, 2012, the Company issued to
Vicis Capital Management an on-demand promissory note for $600 thousand. The note accrued interest at 10% per annum. As of January
31, 2013 the Company had not repaid the note plus accrued interest of $44.9 thousand.